Caricamento...
HPV16E6 antibodies are sensitive for HPV-driven oropharyngeal cancer and associated with recurrence
BACKGROUND: HPV16E6 antibodies may be an early marker of HPV-driven oropharyngeal cancer (HPV-OPC) diagnosis and recurrence. METHODS: We identified 161 incident OPCs diagnosed at the University of Pittsburgh (2003–2013) with pre-treatment serum; 112 had pre-existing clinical HPV testing with p16 imm...
Salvato in:
| Pubblicato in: | Cancer |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743332/ https://ncbi.nlm.nih.gov/pubmed/28950407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30966 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|